International Stem Cell Corp. (ISCO) Co-Chairman and CEO Issues Shareholder Letter
Today before the opening bell, International Stem Cell Corp. reported that Co-Chairman of the Board and Chief Executive Officer Andrey Semechkin PhD has published an open letter to shareholders. Dr. Semechkin’s letter provides an update on the stem cell company’s research and development accomplishments, future expectations and anticipated milestones, along with a discussion of ISCO's expanded intellectual property portfolio and a summary of the company's commercial and financial performance for the first nine months of 2013. The full text of the letter can be found at http://www.internationalstemcell.com/2014_Shareholder_Letter International Stem Cell Corp. specializes in the therapeutic applications of human stem cells…